Domain Summary
Global Traffic Rank | n/a |
---|---|
Estimated Visitors | 0 visitors per month |
Domain Creation Date | n/a |
Web Server Location | United States |
Frequently Asked Questions (FAQ)
When was Seretide.co.nz registered?Seretide.co.nz was registered on n/a.
|
When will Seretide.co.nz expire?This domain will expire in n/a on n/a.
|
What are Seretide.co.nz's nameservers?DNS for Seretide.co.nz is provided by the nameservers
ns-1327.awsdns-37.org,
ns-2044.awsdns-63.co.uk,
ns-398.awsdns-49.com,
ns-904.awsdns-49.net,
|
Who is the registrar for the Seretide.co.nz domain?The domain has been registered at .
|
What is the traffic rank for Seretide.co.nz?Seretide.co.nz ranks
n/a
globally on Alexa.
|
What IP addresses does Seretide.co.nz resolve to?Seretide.co.nz resolve to 52.207.1.121.
|
In what country are Seretide.co.nz servers located in?Seretide.co.nz has servers located in the
United States .
|
Website and Web Server Information
Website Host | https://seretide.co.nz |
---|---|
Title: | Breo Ellipta | Treat asthma with one puff, once a day |
Description: | Breathe better with the Breo Ellipta inhaler, the once daily asthma treatment for long-term relief and prevention of symptoms. |
Keywords: | Ellipta, Breo Ellipta, Breo, Breo NZ, Vilanterol, Fluticasone furoate, COPD, Lung Disease, Lung, Smoking, Smokers Cough, Chronic Bronchitis, Emphysema, Asthma, Asthma NZ, Asthma Symptoms, Asthma Treatment, Asthma Inhaler, Inhaler, LAMA, LABA, GSK, Ventolin, Seretide, Flixotide Allergic Asthma |
Domain WHOIS Record
Domain Creation Date | |
---|---|
Domain Expiry Date | |
Nameservers |
|
Whois |
|
DNS Resource Records
Name | Type | Data |
---|---|---|
@ | A |
ip: 52.207.1.121 |
@ | A |
ip: 23.20.205.248 |
@ | MX |
pri: 10 target: mailaws.imgw.com |
@ | NS |
target: ns-1327.awsdns-37.org |
@ | NS |
target: ns-2044.awsdns-63.co.uk |
@ | NS |
target: ns-398.awsdns-49.com |
@ | NS |
target: ns-904.awsdns-49.net |
@ | SOA |
mname: ns-904.awsdns-49.net rname: awsdns-hostmaster.amazon.com serial: 1 refresh: 7200 retry: 900 expire: 1209600 minimum-ttl: 86400 |
@ | TXT |
txt: facebook-domain-verification=tlirg1kvwv04mafya94zu40q1zltg7 |
HTTP Headers
Date: Thu, 26 Nov 2020 00:32:20 GMT Content-Type: text/html Connection: keep-alive Set-Cookie: AWSALB=3uqfUPp077J5d+eDBygI5gU2mvbiKwcwNifcXjyEgPFSJft38Nan8l/yNxB9NJInI/VcznWDRnuJz4cwN0yU09yS/OdOvmsH7k7GNfiY33CDaSO0/b11nrxzDCzo; Expires=Thu, 03 Dec 2020 00:32:20 GMT; Path=/ Set-Cookie: AWSALBCORS=3uqfUPp077J5d+eDBygI5gU2mvbiKwcwNifcXjyEgPFSJft38Nan8l/yNxB9NJInI/VcznWDRnuJz4cwN0yU09yS/OdOvmsH7k7GNfiY33CDaSO0/b11nrxzDCzo; Expires=Thu, 03 Dec 2020 00:32:20 GMT; Path=/; SameSite=None; Secure Last-Modified: Tue, 22 Sep 2020 21:15:02 GMT Accept-Ranges: bytes ETag: "e30736f2591d61:0" Vary: Accept-Encoding X-Powered-By: ASP.NET Strict-Transport-Security: max-age=31536000; includeSubDomains X-Frame-Options: DENY X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Referrer-Policy: strict-origin Strict-Transport-Security-1: max-age=31536000; includeSubDomains X-Frame-Options-1: DENY X-XSS-Protection-1: 1; mode=block X-Content-Type-Options-1: nosniff Referrer-Policy-1: strict-origin x-encoded-content-encoding: gzip x-encoded-content-length: 5210 |